Hepatic Impairment Following oral administration of one 4 mg dose (2 mg hydromorphone rapid-release tablets), suggest exposure to hydromorphone (Cmax and AUC?) is increased 4-fold in individuals with average (Boy or girl-Pugh Group B) hepatic impairment when compared with topics with regular hepatic operate. Because of greater exposure of hydromorp